Showing results (351-360 of 384) with videos related to
Sort By:
Pageof 39
Cancer|June 1, 1983
The relationship between family history, exposure to exogenous hormones, and estrogen receptor protein in breast cancerM P Osborne, P P Rosen, M L Lesser, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2019
Correction to: 18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumorsLaure Michaud, B J Beattie, T Akhurst, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2020
Comparison of 68Ga-DOTA-JR11 PET/CT with dosimetric 177Lu-satoreotide tetraxetan (177Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapySimone Krebs, Joseph A O'Donoghue, Evan Biegel, et al.Pharmaceutical Research|December 11, 2012
(89)Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancerDiane S Abou, Daniel L J Thorek, Nicholas N Ramos, et al.Journal of Neuro-Oncology|November 24, 2017
A pilot study of neuropsychological functions, APOE and amyloid imaging in patients with gliomasD D Correa, M Kryza-Lacombe, X Zhou, et al.Preventive Veterinary Medicine|November 14, 2006
Hydrographics and the timing of infectious salmon anemia outbreaks among Atlantic salmon (Salmo salar L.) farms in the Quoddy region of Maine, USA and New Brunswick, CanadaL L Gustafson, S K Ellis, M J Beattie, et al.Cancer Biotherapy & Radiopharmaceuticals|September 23, 2022
Radiochemical Quality Control Methods for Radium-223 and Thorium-227 RadiotherapiesAbbie Hasson, Wen Jiang, Nadia Benabdallah, et al.Science Translational Medicine|March 25, 2016
Targeted fibrillar nanocarbon RNAi treatment of acute kidney injurySimone Alidori, Nima Akhavein, Daniel L J Thorek, et al.The Journal of Thoracic and Cardiovascular Surgery|February 21, 2023
Factors associated with morbidity, mortality, and hemodynamic failure after biventricular conversion in borderline hypoplastic left heartsMeaghan J Beattie, Lynn A Sleeper, Minmin Lu, et al.Theranostics|June 1, 2019
Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranosticsOskar Vilhelmsson Timmermand, Jörgen Elgqvist, Kai A Beattie, et al.Pageof 39